Cargando…
Current Progress of Virus-mimicking Nanocarriers for Drug Delivery
Nanomedicines often involve the use of nanocarriers as a delivery system for drugs or genes for maximizing the therapeutic effect and/or minimizing the adverse effect. From drug administration to therapeutic activity, nanocarriers must evade the host's immune system, specifically and efficientl...
Autores principales: | Somiya, Masaharu, Liu, Qiushi, Kuroda, Shun'ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704007/ https://www.ncbi.nlm.nih.gov/pubmed/29188175 http://dx.doi.org/10.7150/ntno.21723 |
Ejemplares similares
-
Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule
por: Liu, Qiushi, et al.
Publicado: (2016) -
Reporter gene assay for membrane fusion of extracellular vesicles
por: Somiya, Masaharu, et al.
Publicado: (2021) -
Polymerized Albumin Receptor of Hepatitis B Virus for Evading the Reticuloendothelial System
por: Takagi, Kurumi, et al.
Publicado: (2021) -
Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
por: Uchida, Noriyuki, et al.
Publicado: (2021) -
HBV Pre-S1-Derived Myristoylated Peptide (Myr47): Identification of the Inhibitory Activity on the Cellular Uptake of Lipid Nanoparticles
por: Nanahara, Masaya, et al.
Publicado: (2021)